PTC Therapeutics, Inc.
PTC Therapeutics, Inc. logo
PTCT

PTC Therapeutics, Inc. (PTCT)

$38.140.37%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$38.01
Day's Range
$38.81
$25.01
52-Week Range
$55.58
1 month return0.24%
3 month return28.13%
1 year return7.83%
5 year return134.71%

Company Information

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and its mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.
OrganizationPTC Therapeutics, Inc.
Employees1167
CEODr. Stuart W. Peltz Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 11 analysts ratings

Buy
45%
Buy
45%
Hold
9%
Sell

Based on 11 Wall street analysts offering stock ratings for PTC Therapeutics, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 34.92%

Current

$38.14

Target

$51.46

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
5
12
10
Hold
5
7
6
Sell
1
1
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
2.8B
Book Value
$0.02
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-7.38
PEG Ratio
0.81
Wall Street Target Price
51.46

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1743.27
Enterprise Value
3.2B
Enterprise Value/Revenue
4.59
Enterprise Value/Ebitda
-9.43

Technicals

Beta
0.47
50 Day MA
43.24
200 Day MA
41.42

Institutional Holdings

FMR Inc

14.66%

Wellington Management Company LLP

10.26%

Vanguard Group Inc

9.88%

BlackRock Inc

8.37%

RTW INVESTMENTS, LLC

7.7%

Franklin Resources Inc

6.73%

Discover more

Frequently Asked Questions

What is PTC Therapeutics, Inc. share price today?

Can Indians buy PTC Therapeutics, Inc. shares?

How can I buy PTC Therapeutics, Inc. shares from India?

Can Fractional shares of PTC Therapeutics, Inc. be purchased?

What are the documents required to start investing in PTC Therapeutics, Inc. stocks?

What are today’s High and Low prices of PTC Therapeutics, Inc.?

What are today’s traded volumes of PTC Therapeutics, Inc.?

What is today’s market capitalisation of PTC Therapeutics, Inc.?

What is the 52 Week High and Low Range of PTC Therapeutics, Inc.?

How much percentage PTC Therapeutics, Inc. is down from its 52 Week High?

How much percentage PTC Therapeutics, Inc. is up from its 52 Week low?

What are the historical returns of PTC Therapeutics, Inc.?

Who is the Chief Executive Officer (CEO) of PTC Therapeutics, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*